← FDA Drug Approvals (Drugs@FDA)

EPZICOM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2016-01-15

Drug application

FDA Application #

ANDA204004

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPZICOM

Generic name

Abacavir

Active ingredients

ABACAVIR; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MYLAN PHARMS INC

First approval

2016-01-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown